Stockreport

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- FibroBiologics (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pendi [Read more]